NO20010358L - Innkapsling av vannløselige peptider - Google Patents

Innkapsling av vannløselige peptider

Info

Publication number
NO20010358L
NO20010358L NO20010358A NO20010358A NO20010358L NO 20010358 L NO20010358 L NO 20010358L NO 20010358 A NO20010358 A NO 20010358A NO 20010358 A NO20010358 A NO 20010358A NO 20010358 L NO20010358 L NO 20010358L
Authority
NO
Norway
Prior art keywords
water
encapsulation
soluble peptides
peptides
soluble
Prior art date
Application number
NO20010358A
Other languages
English (en)
Other versions
NO20010358D0 (no
Inventor
Francis X Ignatious
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/014869 external-priority patent/WO2000004916A1/en
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20010358D0 publication Critical patent/NO20010358D0/no
Publication of NO20010358L publication Critical patent/NO20010358L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av bionedbrytbare mikrokuler og eller nanosfærer ved anvendelse av en olje-i-vann prosess for kontrollert frigjøring av bioaktive peptider.
NO20010358A 1998-07-23 2001-01-22 Innkapsling av vannløselige peptider NO20010358L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12165398A 1998-07-23 1998-07-23
US9391498P 1998-07-23 1998-07-23
PCT/US1999/014869 WO2000004916A1 (en) 1998-07-23 1999-07-09 Encapsulation of water soluble peptides

Publications (2)

Publication Number Publication Date
NO20010358D0 NO20010358D0 (no) 2001-01-22
NO20010358L true NO20010358L (no) 2001-03-22

Family

ID=26788040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010358A NO20010358L (no) 1998-07-23 2001-01-22 Innkapsling av vannløselige peptider

Country Status (12)

Country Link
EP (1) EP1098660B1 (no)
JP (1) JP2002521343A (no)
AR (1) AR019466A1 (no)
AT (1) ATE226083T1 (no)
AU (1) AU4964699A (no)
CA (1) CA2338345A1 (no)
DE (1) DE69903553T2 (no)
DK (1) DK1098660T3 (no)
ES (1) ES2185373T3 (no)
NO (1) NO20010358L (no)
PT (1) PT1098660E (no)
RU (1) RU2216343C2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
MY158342A (en) * 2003-11-14 2016-09-30 Novartis Ag Pharmaceutical composition
JP4872813B2 (ja) * 2007-06-08 2012-02-08 栗田工業株式会社 透過膜の阻止率向上方法および透過膜処理方法
JP4568335B2 (ja) * 2008-02-04 2010-10-27 三洋化成工業株式会社 抗体含有溶液コントロール試薬
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
CN103079546A (zh) * 2010-08-20 2013-05-01 天蓝制药公司 治疗性肽-聚合物缀合物、粒子、组合物以及相关方法
WO2013101749A1 (en) * 2011-12-29 2013-07-04 Latitude Pharmaceuticals, Inc. Stabilized glucagon nanoemulsions
WO2016069409A1 (en) 2014-10-27 2016-05-06 Latitude Pharmaceuticals, Inc. Parenteral glucagon formulations
US10039801B2 (en) 2016-02-16 2018-08-07 Strongbridge Ireland Limited Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use

Also Published As

Publication number Publication date
EP1098660A1 (en) 2001-05-16
ATE226083T1 (de) 2002-11-15
ES2185373T3 (es) 2003-04-16
CA2338345A1 (en) 2000-02-03
EP1098660B1 (en) 2002-10-16
JP2002521343A (ja) 2002-07-16
DE69903553T2 (de) 2003-06-26
PT1098660E (pt) 2003-02-28
AR019466A1 (es) 2002-02-20
NO20010358D0 (no) 2001-01-22
DE69903553D1 (de) 2002-11-21
AU4964699A (en) 2000-02-14
RU2216343C2 (ru) 2003-11-20
DK1098660T3 (da) 2003-02-17

Similar Documents

Publication Publication Date Title
AU4230797A (en) Powders providing controlled sustained release of a gas
AU2001259108A1 (en) Methods and systems for generating source code for object-oriented elements
AU4489197A (en) Radially expanding prostheses and systems for their deployment
IT1294865B1 (it) Dispositivo e procedimento per la formatura di strutture di tecniche microsistemiche.
ZA961205B (en) Aqueous lecithin-based release aids and methods of using the same
MXPA01008882A (es) Metodo y sistema para el descubrimiento de cookies y otra informacion del cliente.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
AU2001274013A1 (en) System and method for enabling the provision of goods or services
BG104511A (en) Spheroids, preparation method and pharmaceutical compositions
WO2000044844A8 (en) Release liners and processes for making the same
NO20010358L (no) Innkapsling av vannløselige peptider
HUP9904065A2 (hu) Olanzapint tartalmazó bevonatos gyógyszerkészítmények
NO903594D0 (no) Fremgangsmaate for pulverisering av materialer, og anlegg til gjennomfoering av dette.
DE69633257D1 (de) Bremse sowie Betätigungsvorrichtung hierfür
AU6769698A (en) Device for enhancing the brilliancy of jewelry
CA2245425A1 (en) Neospora vaccine
DE69608959D1 (de) Chlamydia impfstoffen
CA2177000A1 (en) Inflator
NO994054L (no) Anker og fremgangsmaate for frigjöring av slikt anker
EP0753915A3 (en) Semiconductor laser for pumping an optical amplifier and method of manufacturing the semiconductor laser
AU5420099A (en) Method and aid for the early recognition of sunburn
TR199600880A2 (tr) Gözenekli ve parcali mallarin otoklavlama islemi icin usul.
AU6538898A (en) Method and apparatus for altering the osmotic pressure of cryopreserved white stem cells
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf
ES2165802A1 (es) Disposicion de soporte perfeccionado aplicable sobre triangulos de preseñalizacion.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application